Treatments and cardiovascular prevention in type 2 mellitus;Traitements des facteurs de risque cardiovasculaire et dépistage de la maladie coronarienne dans le diabète de type 2

Revue Medicale Suisse

Volumn 6, Issue 252, 2010, Pages 1176-1181

  Ruiz, Juan ^a   Egli, Marc ^a   Gianinazzi, Francesco ^b   Izzo, Filomena ^a   Rossi, Ilario ^c   Voeffray Favre, Anne Cristine ^c   Bodenmann, Patrick ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Hôpital d Yverdon les Bains   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; HEART MUSCLE ISCHEMIA; HYPERTENSION; HYPOGLYCEMIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANTILIPEMIC AGENTS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; MASS SCREENING; PROCETOFEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77954106573     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl. 2):B21-9.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-13.
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)
5. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
6. Imperatore G, Cadwell BL, Geiss L, et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National health and nutrition examination surveys, 1971-2000. Am J Epidemiol 2004;160:531-9.
7. Buse JB, Bigger JT, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods. Am J Cardiol 2007;99:21i-33i.
8. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
9. * ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85.
10. * ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010;362:1563-74.
11. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998;21:1551-9.
12. Puel J, Valensi P, Vanzetto G, et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004;30(3 Pt 3):3S-18.
13. * Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004;27:1954-61.
14. Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA 2009;301:1547-55.
15. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909.
16. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
17. Shapiro AR. The UGDP mortality results. JAMA 1972;219:1761-2.